ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Dispute At City of Hope Pits Center Against For-Profit Physician Group.

May 28, 2010

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

Obituary: Paul Rogers, Former Congressman, Instrumental In National Cancer Act Passage.

October 17, 2008

Physician Clinical Investigator Awards

April 15, 1983

Yates Identifies “Probable”, “Potential” Core Grant Applicants

January 16, 1987

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982